Basic Info

Abbott Laboratories (ABT) - Diagnostics Revenue is at a current level of 9.341B, down from 9.988B one year ago. This is a change of -6.48% from one year ago.

Abbott Laboratories Diagnostics Revenue refers to the income generated by the company's division that specializes in developing, manufacturing, and selling diagnostic tests and diagnostic instruments.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 9.341B
Latest Period 2024
Last Updated Jan 31 2025, 08:41 EST
Next Release Jan 31 2026, 08:30 EST (E)
Average Growth Rate 9.07%
Value from 1 Year Ago 9.988B
Change from 1 Year Ago -6.48%
Frequency Yearly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2024 9.341B
December 31, 2023 9.988B
December 31, 2022 16.47B
December 31, 2021 15.53B
December 31, 2020 10.80B
December 31, 2019 7.713B
December 31, 2018 7.495B
Date Value
December 31, 2017 5.616B
December 31, 2016 4.813B
December 31, 2015 4.646B
December 31, 2014 4.721B
December 31, 2013 4.545B
December 31, 2012 4.292B

Basic Info

Abbott Laboratories (ABT) - Diagnostics Revenue is at a current level of 9.341B, down from 9.988B one year ago. This is a change of -6.48% from one year ago.

Abbott Laboratories Diagnostics Revenue refers to the income generated by the company's division that specializes in developing, manufacturing, and selling diagnostic tests and diagnostic instruments.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 9.341B
Latest Period 2024
Last Updated Jan 31 2025, 08:41 EST
Next Release Jan 31 2026, 08:30 EST (E)
Average Growth Rate 9.07%
Value from 1 Year Ago 9.988B
Change from 1 Year Ago -6.48%
Frequency Yearly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
ABT Abbott Laboratories -0.15%
Quickflows
Search for a securityto view Quickflows